$PHLT
Performant Healthcare Inc Stock $phlt

$phlt Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000155069521000007 Filed on March 22, 2021

Income Statement

Concept	2019 Q4	2019	2018 Q4
Revenue	$43.82M	$150.4M	$39.73M
YoY Change	10.29%	-3.36%	19.35%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$28.38M	$115.2M	$27.78M
YoY Change	2.16%	19.88%	35.18%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.840M	$8.536M	$2.630M
YoY Change	-30.04%	-16.59%	4.78%
% of Gross Profit
Operating Expenses	$38.95M	$170.1M	$40.19M
YoY Change	-3.09%	8.01%	20.33%
Operating Profit		-$19.65M
YoY Change		993.43%
Interest Expense	-$2.320M	$7.589M	-$1.160M
YoY Change	100.0%	61.5%	-10.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.650M	-$27.20M	-$4.610M
YoY Change	0.87%	320.49%	86.64%
Income Tax	-$790.0K	-$377.0K	$660.0K
% Of Pretax Income
Net Earnings	-$3.860M	-$26.82M	-$5.270M
YoY Change	-26.76%	235.25%	-1113.46%
Net Earnings / Revenue	-8.81%	-17.83%	-13.26%
Basic Earnings Per Share		-$0.50
Diluted Earnings Per Share	-$71.79K	-$0.50	-$99.43K
COMMON SHARES
Basic Shares Outstanding	53.71M shares	53.47M shares	52.99M shares
Diluted Shares Outstanding		53.47M shares

Balance Sheet

Concept	2019 Q4	2019	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.400M	$3.400M	$5.500M
YoY Change	-38.18%	-38.18%	-74.65%
Cash & Equivalents	$3.373M	$3.400M	$5.462M
Short-Term Investments
Other Short-Term Assets	$4.900M	$4.900M	$5.200M
YoY Change	-5.77%	-5.77%	-64.14%
Inventory
Prepaid Expenses
Receivables	$27.17M	$28.50M	$20.88M
Other Receivables	$200.0K	$200.0K	$200.0K
Total Short-Term Assets	$37.00M	$37.00M	$31.75M
YoY Change	16.51%	16.35%	-42.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.77M	$25.60M	$22.26M
YoY Change	-15.66%	14.8%	6.26%
Goodwill	$74.40M		$81.60M
YoY Change	-8.82%		0.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	-33.33%
Total Long-Term Assets	$101.9M	$101.9M	$106.0M
YoY Change	-3.9%	-3.87%	-2.66%
TOTAL ASSETS
Total Short-Term Assets	$37.00M	$37.00M	$31.75M
Total Long-Term Assets	$101.9M	$101.9M	$106.0M
Total Assets	$138.9M	$138.9M	$137.8M
YoY Change	0.81%	0.8%	-16.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.532M	$2.500M	$1.402M
YoY Change	80.6%	78.57%	-7.64%
Accrued Expenses	$2.200M	$8.900M	$5.800M
YoY Change	-62.07%	53.45%	26.09%
Deferred Revenue	$100.0K		$1.078M
YoY Change	-90.72%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.320M	$3.300M	$2.224M
YoY Change	49.28%	50.0%	9.61%
Total Short-Term Liabilities	$19.43M	$19.40M	$14.09M
YoY Change	37.93%	37.59%	-67.3%
LONG-TERM LIABILITIES
Long-Term Debt	$58.56M	$58.60M	$41.11M
YoY Change	42.47%	42.58%	6.61%
Other Long-Term Liabilities	$1.796M	$7.200M	$3.383M
YoY Change	-46.91%	35.85%	36.63%
Total Long-Term Liabilities	$60.36M	$65.80M	$60.53M
YoY Change	-0.29%	41.81%	-28.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.43M	$19.40M	$14.09M
Total Long-Term Liabilities	$60.36M	$65.80M	$60.53M
Total Liabilities	$85.25M	$85.20M	$60.53M
YoY Change	40.83%	40.83%	-28.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.97M		-$149.0K
YoY Change	18000.0%		-101.9%
Common Stock	$80.59M		$77.38M
YoY Change	4.16%		6.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.63M	$53.60M	$77.23M
YoY Change
Total Liabilities & Shareholders Equity	$138.9M	$138.9M	$137.8M
YoY Change	0.81%	0.8%	-16.22%

Cashflow Statement

Concept	2019 Q4	2019	2018 Q4
OPERATING ACTIVITIES
Net Income	-$3.860M	-$26.82M	-$5.270M
YoY Change	-26.76%	235.25%	-1113.46%
Depreciation, Depletion And Amortization	$1.840M	$8.536M	$2.630M
YoY Change	-30.04%	-16.59%	4.78%
Cash From Operating Activities	-$2.040M	-$15.42M	-$2.280M
YoY Change	-10.53%	27.46%	-203.64%
INVESTING ACTIVITIES
Capital Expenditures	-$760.0K	$4.856M	-$1.330M
YoY Change	-42.86%	-36.48%	-28.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$620.0K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$760.0K	-$4.856M	-$710.0K
YoY Change	7.04%	-9.4%	-61.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-750.0K	$18.00M	2.860M
YoY Change	-126.22%	1287.74%	-14400.0%
NET CHANGE
Cash From Operating Activities	-2.040M	-$15.42M	-2.280M
Cash From Investing Activities	-760.0K	-$4.856M	-710.0K
Cash From Financing Activities	-750.0K	$18.00M	2.860M
Net Change In Cash	-3.550M	-$2.280M	-130.0K
YoY Change	2630.77%	-85.96%	-139.39%
FREE CASH FLOW
Cash From Operating Activities	-$2.040M	-$15.42M	-$2.280M
Capital Expenditures	-$760.0K	$4.856M	-$1.330M
Free Cash Flow	-$1.280M	-$20.28M	-$950.0K
YoY Change	34.74%	2.7%	-123.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	City Area Code CityAreaCode	(925)
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001550695
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54824982	shares
CY2020Q2	dei	Entity Public Float EntityPublicFloat	7197219	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54764000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53900000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54764000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53900000	shares
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Local Phone Number LocalPhoneNumber	960-4800
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-35628
CY2020	dei	Entity Registrant Name EntityRegistrantName	PERFORMANT FINANCIAL CORPORATION
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0484934
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	333 North Canyons Parkway
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Livermore
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94551
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001 per share
CY2020	dei	Trading Symbol TradingSymbol	PFMT
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020Q2	dei	Entity Public Float EntityPublicFloat	7197219	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54824982	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16043000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3373000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2253000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1622000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	49000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	237000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23216000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27170000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	4466000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1339000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3784000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3329000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	4758000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	164000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	54520000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	36997000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17497000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18769000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	689000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8799000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	925000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	47372000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	74372000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5043000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6834000	USD
CY2020Q4	pfmt	Other Assets Net OtherAssetsNet	1106000	USD
CY2019Q4	pfmt	Other Assets Net OtherAssetsNet	975000	USD
CY2020Q4	us-gaap	Assets Assets	126227000	USD
CY2019Q4	us-gaap	Assets Assets	138872000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	906000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	130000	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	59957000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3320000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6126000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	407000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2532000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3841000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3576000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	867000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	83000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1014000	USD
CY2019Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1018000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2327000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2775000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	77212000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19430000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	2301000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	58562000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	89000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	475000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3442000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4984000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3504000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1796000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	84247000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	85247000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82933000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	80589000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40958000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26969000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41980000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	53625000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126227000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138872000	USD
CY2020	us-gaap	Revenues Revenues	155937000	USD
CY2019	us-gaap	Revenues Revenues	150432000	USD
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	100654000	USD
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	115194000	USD
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	42248000	USD
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	47687000	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	27000000	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7200000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	169902000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	170081000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13965000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-19649000	USD
CY2020	us-gaap	Interest Expense InterestExpense	7227000	USD
CY2019	us-gaap	Interest Expense InterestExpense	7589000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	21000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	41000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21171000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27197000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7182000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-377000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13989000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26820000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54414000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53468000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54414000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53468000	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	77226000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-433000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2311000	USD
CY2019	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1165000	USD
CY2019	pfmt	Stock Issued During Period Value Earnout Shares StockIssuedDuringPeriodValueEarnoutShares	176000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-26820000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	53625000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-266000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2610000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13989000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41980000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-13989000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-26820000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-88000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-57000	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	27000000	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7200000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5216000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8536000	USD
CY2020	pfmt	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	1791000	USD
CY2019	pfmt	Operating Lease Rightof Use Asset Amortization OperatingLeaseRightofUseAssetAmortization	2589000	USD
CY2020	pfmt	Gain Loss On Modification Of Lease GainLossOnModificationOfLease	0	USD
CY2019	pfmt	Gain Loss On Modification Of Lease GainLossOnModificationOfLease	137000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2610000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	2311000	USD
CY2020	pfmt	Interest Expense Debt Issuance Costs And Amortization InterestExpenseDebtIssuanceCostsAndAmortization	1525000	USD
CY2019	pfmt	Interest Expense Debt Issuance Costs And Amortization InterestExpenseDebtIssuanceCostsAndAmortization	1286000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-398000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1223000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3954000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6291000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	3127000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1339000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	455000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-91000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4594000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-15000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	135000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-40000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2673000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	367000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2125000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1130000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1061000	USD
CY2019	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-895000	USD
CY2020	pfmt	Increase Decreasein Estimated Liability For Appeals IncreaseDecreaseinEstimatedLiabilityForAppeals	-4000	USD
CY2019	pfmt	Increase Decreasein Estimated Liability For Appeals IncreaseDecreaseinEstimatedLiabilityForAppeals	808000	USD
CY2020	pfmt	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability	-1990000	USD
CY2019	pfmt	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability	-2786000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1708000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-362000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20809000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15423000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3792000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4856000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3792000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4856000	USD
CY2020	pfmt	Repayments Of Long Term Notes Payable RepaymentsOfLongTermNotesPayable	3450000	USD
CY2019	pfmt	Repayments Of Long Term Notes Payable RepaymentsOfLongTermNotesPayable	2488000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	81000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	266000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	466000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34000	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	21000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3716000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17999000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13301000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2280000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4995000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7275000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18296000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4995000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16043000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3373000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2253000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1622000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18296000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4995000	USD
CY2020	pfmt	Stock Issued During Period Value Earnout Shares StockIssuedDuringPeriodValueEarnoutShares	0	USD
CY2019	pfmt	Stock Issued During Period Value Earnout Shares StockIssuedDuringPeriodValueEarnoutShares	176000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	1165000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2257000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-202000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	5702000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	6304000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates in the Preparation of Consolidated Financial Statements<div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, intangible assets, goodwill, estimated liability for appeals and disputes, lease liabilities, earnout payable, other liabilities, deferred income taxes and income tax expense (benefit), and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Our actual results could differ from those estimates.</span></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:6.34pt">Liquidity</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying consolidated financial statements have been prepared on a going concern basis which contemplates that the Company will be able to realize assets and discharge its liabilities in the normal course of business. Accordingly, they do not give effect to any adjustments that would be necessary should the Company be required to liquidate its assets. The ability of the Company to continue to fund its business plans is dependent upon realizing sufficient cash flows in the future. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its forecasted results will be sufficient to fund the Company’s current operations, for at least a year from the issuance of these consolidated financial statements. While the Company believes its financial projections are attainable, there can be no assurances that the financial results will be recognized in a timeframe necessary to meet the Company’s ongoing cash requirements. To address the Company’s liquidity needs, specifically the $60.9 million of loans outstanding at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">December 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company has the option to extend the maturity of the loans for two additional one-year periods, subject to the satisfaction of customary conditions, including certain financial covenants. If the Company fails to satisfy the conditions required to exercise the option to extend the maturity of the loans, the full balance of the loans will come due on </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">August 11, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at which time, the Company may not have sufficient cash resources to satisfy its debt obligations and the Company may not be able to continue its operations as planned.</span>
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2300000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1600000	USD
CY2020	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	Impairment of Long-Lived AssetsLong-lived assets, including intangible assets subject to amortization, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.
CY2020	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5400000	USD
CY2019	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	4000000.0	USD
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	3100000	USD
CY2019	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	5800000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	155937000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150432000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50000.00	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	200000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1000000.0	USD
CY2019Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	1000000.0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4500000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1300000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	900000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3800000	USD
CY2020Q4	pfmt	Prepaid Expenseand Other Assets Prepaid Software Licenses And Maintenance Agreements PrepaidExpenseandOtherAssetsPrepaidSoftwareLicensesAndMaintenanceAgreements	1800000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1400000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	600000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3300000	USD
CY2019Q4	pfmt	Prepaid Expenseand Other Assets Prepaid Software Licenses And Maintenance Agreements PrepaidExpenseandOtherAssetsPrepaidSoftwareLicensesAndMaintenanceAgreements	2200000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	700000	USD
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	400000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3400000	USD
CY2020Q4	pfmt	Workers Compensation Liability Incurred WorkersCompensationLiabilityIncurred	200000	USD
CY2020Q4	pfmt	Premium Insurance Financing Payables PremiumInsuranceFinancingPayables	200000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2200000	USD
CY2019Q4	pfmt	Premium Insurance Financing Payables PremiumInsuranceFinancingPayables	600000	USD
CY2019Q4	pfmt	Accrued Subcontractor Fees Current AccruedSubcontractorFeesCurrent	300000	USD
CY2019Q4	pfmt	Workers Compensation Liability Incurred WorkersCompensationLiabilityIncurred	300000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54414000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53468000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54414000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53468000	shares
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	59957000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	59957000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	95814000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	95390000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78317000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76621000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17497000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18769000	USD
CY2020	us-gaap	Depreciation Depreciation	5000000.0	USD
CY2019	us-gaap	Depreciation Depreciation	8300000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	47400000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	74400000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	27000000.0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7200000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	60863000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	906000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	3000000.0	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	3300000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	3000000.0	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	3500000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	6.6
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	6.3
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2642000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1939000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	819000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	585000	USD
CY2020Q4	pfmt	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	398000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6383000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	614000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5769000	USD
CY2012Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2012Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2600000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2300000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	273000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0.0	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0.0	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0.0	USD
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0.0	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0.0	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000.00	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-7164000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-18000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-390000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-7182000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-390000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	13000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7182000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-377000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02
CY2020	pfmt	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.05
CY2019	pfmt	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.27
CY2020	pfmt	Effective Income Tax Rate Reconciliation Work Opportunity Credit Percent EffectiveIncomeTaxRateReconciliationWorkOpportunityCreditPercent	0.01
CY2019	pfmt	Effective Income Tax Rate Reconciliation Work Opportunity Credit Percent EffectiveIncomeTaxRateReconciliationWorkOpportunityCreditPercent	0.01
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.01
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.02
CY2020	pfmt	Effective Income Tax Rate Reconciliation Cares Act Permanent Rate Benefit Percent EffectiveIncomeTaxRateReconciliationCARESActPermanentRateBenefitPercent	0.14
CY2019	pfmt	Effective Income Tax Rate Reconciliation Cares Act Permanent Rate Benefit Percent EffectiveIncomeTaxRateReconciliationCARESActPermanentRateBenefitPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.29
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.16
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.02
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.34
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	550000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences	514000	USD
CY2020Q4	pfmt	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	2943000	USD
CY2019Q4	pfmt	Deferred Tax Assets Nonqualified Stock Options DeferredTaxAssetsNonqualifiedStockOptions	2873000	USD
CY2020Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	340000	USD
CY2019Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	387000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	452000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	452000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2053000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4519000	USD
CY2020Q4	pfmt	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	1615000	USD
CY2019Q4	pfmt	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	3419000	USD
CY2020Q4	pfmt	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	1568000	USD
CY2019Q4	pfmt	Deferred Tax Asset Lease Liability DeferredTaxAssetLeaseLiability	2098000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1584000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1291000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11105000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15553000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6246000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12809000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4859000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2744000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3042000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	749000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1370000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1848000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	482000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	182000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4894000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2779000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	35000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	35000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6200000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-6600000	USD
CY2020	pfmt	Coronavirus Aid Relief And Economic Securities Cares Act Income Tax Expense Benefit CoronavirusAidReliefAndEconomicSecuritiesCARESActIncomeTaxExpenseBenefit	7600000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1601000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	51000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	282000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1370000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	31000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	346000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1055000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1400000	USD
CY2020Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	200000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	300000	USD
CY2019Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0	USD
CY2019	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0	USD
CY2020	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	0	USD
CY2020Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1100000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	800000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	4300000	USD

Files In Submission

Name	View Source	Status
0001550695-21-000007-index-headers.html	Edgar Link	pending
0001550695-21-000007-index.html	Edgar Link	pending
0001550695-21-000007.txt	Edgar Link	pending
0001550695-21-000007-xbrl.zip	Edgar Link	pending
ex21subsidiaries10k2020.htm	Edgar Link	pending
ex231consent10k2020.htm	Edgar Link	pending
ex311cert10k2020.htm	Edgar Link	pending
ex312cert10k2020.htm	Edgar Link	pending
ex321cert10k2020.htm	Edgar Link	pending
ex322cert10k2020.htm	Edgar Link	pending
ex42securitiesregistered20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfmt-20201231.htm	Edgar Link	pending
pfmt-20201231.xsd	Edgar Link	pending
pfmt-20201231_cal.xml	Edgar Link	unprocessable
pfmt-20201231_def.xml	Edgar Link	unprocessable
pfmt-20201231_g1.jpg	Edgar Link	pending
pfmt-20201231_htm.xml	Edgar Link	completed
pfmt-20201231_lab.xml	Edgar Link	unprocessable
pfmt-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHLT
Performant Healthcare Inc Stock $phlt

2019 Q4 Form 10-K Financial Statement

#000155069521000007 Filed on March 22, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHLT Performant Healthcare Inc Stock $phlt

2019 Q4 Form 10-K Financial Statement

#000155069521000007 Filed on March 22, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHLT
Performant Healthcare Inc Stock $phlt